DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)

[(2S)-1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate

STFDXSFZJYFVLD-WKAQRXBLSA-N CHEBI:170904 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: STFDXSFZJYFVLD-WKAQRXBLSA-N
InChI Key: STFDXSFZJYFVLD-WKAQRXBLSA-N
IUPAC name: [(2S)-1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate
Preferred name: DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
INN name: —
Synonym: —
ChEBI: CHEBI:170904

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h